$SNDX news
The latest SNDX stock news: headlines, filings, AI summaries and sentiment for $SNDX, updated around the clock.
- Pomerantz Law Firm Investigates Syndax Pharmaceuticals Following Failed Phase 2 Clinical Trial
- Syndax Pharmaceuticals Reports 82% Year-Over-Year Revenue Growth in Q3 2026
- Syndax Pharmaceuticals Reports 82% Year-over-Year Revenue Growth in Q3
- Syndax Pharmaceuticals Appoints Aaron Ondrey as CFO Following Keith Goldan's Retirement Announcement
- Syndax Pharmaceuticals Inc - 10-Q Filing
- Syndax Pharmaceuticals Inc - 8-K Filing
- Stocks Making Significant Moves Midday: Apple, Meta Platforms, Bumble, and More
- Premarket Stock Movements: JPMorgan Chase, Micron, UnitedHealth and Others React
- Syndax Pharmaceuticals Shares Drop After Phase 2 Trial Failure for Axatilimab